<?xml version="1.0" encoding="UTF-8"?>
<p id="para0033">As previously mentioned, it is recognized the fact that TLRs are responsible for the activation of inflammatory pathways in obesity state. 
 <italic>In vitro</italic> trials confirmed that alantolactone (
 <bold>6</bold>) prevents the increase of IL-6 levels and regulates macrophage infiltration by reduction of MCP-1 concentrations via inhibition of the TLR4-JNK pathway in both, lean (adipocytes) and obese (adipocyte-macrophage) states (
 <xref rid="bib0067" ref-type="bibr">Kim et al., 2017</xref>a, 
 <xref rid="bib0068" ref-type="bibr">2017b</xref>).
</p>
